Sientra Receives Regulatory Approval to Market OPUS® Breast Implants in Japan
SANTA BARBARA, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified global […]
Itamar Medical Announces Participation in Virtual SLEEP 2020 Conference
CAESAREA, Israel, Aug. 25, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital […]
Krystal Biotech Announces Initiation of Phase 1 Study Evaluating KB301 in Aesthetic Indications
KB103 is designed to deliver a full-length human type III collagen transgene via intradermal injection First in-human study will evaluate the […]
Digital Ally’s ThermoVu™ Temperature Screening Devices to Aid Sporting Kansas City in Safely Welcoming Fans Back to Major League Soccer
MLS is first major men’s league in U.S. to allow fans in attendanceLenexa, KS, Aug. 25, 2020 (GLOBE NEWSWIRE) — […]
Cabaletta Bio Announces Publication of Comprehensive Preclinical Study Results for DSG3-CAART in Pemphigus Vulgaris
DSG3-CAART achieved autoantibody elimination and resolution of blisters in active immune mouse model of pemphigus vulgarisSoluble autoantibodies demonstrated potential to […]
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
NEW YORK, Aug. 25, 2020 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines […]
Altair Joins Avicenna Alliance to Support Simulation-based Development of Medical Breakthroughs
TROY, Mich., Aug. 25, 2020 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global technology company providing solutions in product development, […]
AlloVir to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present […]
Immunovant Announces Positive Topline Results from Multi-Center, Placebo-Controlled Phase 2a Trial of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Myasthenia Gravis
3.8-point mean improvement on the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale was statistically significant vs. placebo (p = […]
ContraFect Announces Funding Agreement with the Cystic Fibrosis Foundation
YONKERS, New York, Aug. 25, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery […]
